Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed Chindex International Inc by 15 percent to $223.6 million after a bidding war for the China-focused hospital chain. The Chinese firm increased its offer to $24 per share from its original $19.50 per share, after an unidentified bidder offered $23 per share in a "superior proposal" earlier this month, according to a filing to the Shanghai Stock Exchange on Monday.Fosun had earlier offered to pay from $193.7 million for Chindex.The acquisition would help Fosun Pharmaceutical increase its access to China's fast-growing private healthcare market. The government is keen to promote investment in the sector to support overburdened public hospitals and bring prices down through increased competition.Chindex runs the premium-end United Family Healthcare hospital chain in China.
Chindex International Inc. is a healthcare company. Shares of CHDX fell by 0.13% or $-0.03/share to $22.94. In the past year, the shares have traded as low as $12.85 and as high as $23.06. On average, 107908 shares of CHDX exchange hands on a given day and today's volume is recorded at 45011.
Source
